Analyst Price Targets — ACN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 20, 2026 10:20 am | — | Wells Fargo | $194.00 | $143.57 | TheFly | Accenture price target lowered to $194 from $200 at Wells Fargo |
| July 10, 2026 10:30 am | Nate Svensson | Deutsche Bank | $136.00 | $139.06 | TheFly | Accenture price target lowered to $136 from $140 at Deutsche Bank |
| July 8, 2026 1:39 pm | Kevin McVeigh | UBS | $275.00 | $139.72 | StreetInsider | UBS Reiterates Buy Rating on Accenture plc (ACN) on Partnership With Google Cloud |
| June 23, 2026 11:12 am | — | Mizuho Securities | $226.00 | $124.83 | TheFly | Accenture price target lowered to $226 from $280 at Mizuho |
| June 22, 2026 12:11 pm | — | Susquehanna | $140.00 | $125.61 | TheFly | Accenture price target lowered to $140 from $186 at Susquehanna |
| June 22, 2026 11:47 am | — | Morgan Stanley | $130.00 | $127.98 | TheFly | Accenture price target lowered to $130 from $177 at Morgan Stanley |
| June 22, 2026 11:36 am | — | Truist Financial | $150.00 | $127.98 | TheFly | Accenture price target lowered to $150 from $210 at Truist |
| June 22, 2026 11:34 am | Daniel Perlin | RBC Capital | $175.00 | $127.98 | TheFly | Accenture price target lowered to $175 from $253 at RBC Capital |
| June 22, 2026 10:45 am | — | Guggenheim | $185.00 | $127.98 | TheFly | Accenture price target lowered to $185 from $225 at Guggenheim |
| June 22, 2026 9:46 am | Jason Kupferberg | Wells Fargo | $200.00 | $127.98 | TheFly | Accenture price target lowered to $200 from $248 at Wells Fargo |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for ACN

US equities advanced during Q2, supported by another quarter of better-than-expected corporate earnings and continued enthusiasm for companies benefiting from artificial intelligence-related investment. Our bottom five contributors to return in Q2 were Accenture, CME Group, Salesforce, Boston Scientific and EOG Resources. Our top five contributors to return in Q2 were Texas Instruments, Lam Research, NXP…

Roper Technologies' bright outlook, software momentum and acquisition gains outweigh Accenture's AI-related risks and weak bookings.

In 1982, the U.S. Securities and Exchange Commission (SEC) adopted Rule 10b-18, providing companies with a safe harbor for qualifying share repurchases. Since then, publicly traded companies have been repurchasing their own shares in order to consolidate ownership and boost earnings per share (EPS).

Boston Common Asset Management LLC cut its position in Accenture PLC (NYSE: ACN) by 75.0% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,604 shares of the information technology services provider's stock after selling 10,840 shares during the quarter. Boston

Accenture plc remains fundamentally strong, trading at a 52% discount to a $291 fair value estimate despite market fears over AI disruption. Q3 2026 results validated ACN's resilience, with 5.6% revenue growth and 8.9% adjusted EPS growth, outperforming analyst expectations. ACN's mid-market expansion, $9 billion acquisition budget, and robust balance sheet underpin 6.5% annual EPS growth forecasts through FY 2028.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
